Carroll Financial Associates’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $24K | Sell |
793
-111
| -12% | -$3.36K | ﹤0.01% | 918 |
|
|
2021
Q3 | $30K | Buy |
904
+21
| +2% | +$697 | ﹤0.01% | 883 |
|
|
2021
Q2 | $35K | Hold |
883
| – | – | ﹤0.01% | 914 |
|
|
2021
Q1 | $39K | Buy |
883
+90
| +11% | +$3.98K | ﹤0.01% | 826 |
|
|
2020
Q4 | $44K | Hold |
793
| – | – | ﹤0.01% | 735 |
|
|
2020
Q3 | $37K | Hold |
793
| – | – | ﹤0.01% | 725 |
|
|
2020
Q2 | $46K | Buy |
793
+152
| +24% | +$8.82K | ﹤0.01% | 673 |
|
|
2020
Q1 | $30K | Hold |
641
| – | – | ﹤0.01% | 700 |
|
|
2019
Q4 | $38K | Buy |
641
+13
| +2% | +$771 | ﹤0.01% | 722 |
|
|
2019
Q3 | $37K | Sell |
628
-164
| -21% | -$9.66K | ﹤0.01% | 682 |
|
|
2019
Q2 | $50K | Buy |
792
+30
| +4% | +$1.89K | ﹤0.01% | 618 |
|
|
2019
Q1 | $61K | Buy |
762
+164
| +27% | +$13.1K | 0.01% | 529 |
|
|
2018
Q4 | $33K | Hold |
598
| – | – | ﹤0.01% | 559 |
|
|
2018
Q3 | $30K | Hold |
598
| – | – | ﹤0.01% | 606 |
|
|
2018
Q2 | $24K | Hold |
598
| – | – | ﹤0.01% | 631 |
|
|
2018
Q1 | $26K | Buy |
598
+500
| +510% | +$21.7K | ﹤0.01% | 605 |
|
|
2017
Q4 | $4K | Hold |
98
| – | – | ﹤0.01% | 1041 |
|
|
2017
Q3 | $5K | Hold |
98
| – | – | ﹤0.01% | 977 |
|
|
2017
Q2 | $4K | Hold |
98
| – | – | ﹤0.01% | 1023 |
|
|
2017
Q1 | $3K | Hold |
98
| – | – | ﹤0.01% | 1053 |
|
|
2016
Q4 | $4K | Hold |
98
| – | – | ﹤0.01% | 974 |
|
|
2016
Q3 | $3K | Hold |
98
| – | – | ﹤0.01% | 1029 |
|
|
2016
Q2 | $2K | Hold |
98
| – | – | ﹤0.01% | 1050 |
|
|
2016
Q1 | $3K | Buy |
98
+43
| +78% | +$1.32K | ﹤0.01% | 993 |
|
|
2015
Q4 | $3K | Hold |
55
| – | – | ﹤0.01% | 949 |
|
|
2015
Q3 | $2K | Hold |
55
| – | – | ﹤0.01% | 970 |
|
|
2015
Q2 | $3K | Buy |
55
+24
| +77% | +$1.31K | ﹤0.01% | 933 |
|
|
2015
Q1 | $2K | Buy |
+31
| New | +$2K | ﹤0.01% | 729 |
|